Michael Zoratti - McMaster Experts

Affiliations

Faculty of Health Sciences, McMaster University
Health Research Methods, Evidence, and Impact (Internal), Faculty of Health Sciences
Assistant Professor (Part-Time), Health Research Methods, Evidence, and Impact, Faculty of Health Sciences

Scholarly Activity in McMaster Experts

Co-author Network

Scholarly Activity
Background
Contact
View All

selected scholarly activity

conferences
- Clinical outcomes associated with azacitidine (AZA) monotherapy for treatment-naive, higher-risk myelodysplastic syndrome (HR-MDS): A systematic literature review and meta-analysis.. Journal of Clinical Oncology. 2022
- Treatment outcomes for newly diagnosed, untreated TP53-mutated acute myeloid leukemia: A systematic review and meta-analysis.. Journal of Clinical Oncology. E19020-E19020. 2022
- IMPROVING THE APPLICATION OF PUBLISHED HEALTH UTILITIES IN COST-UTILITY ANALYSES: DEVELOPMENT OF THE HEALTH UTILITY APPLICATION TOOL (HAT). Value in Health. S286-S287. 2020
- PCN41 THE HEALTH UTILITY BOOK (HUB): A REGISTRY OF HEALTH STATE UTILITY VALUES IN ONCOLOGY. Value in Health. S63-S63. 2019
- PCN42 THE HEALTH UTILITY BOOK (HUB): TOWARD A CENTRALIZED, SYSTEMATIC APPROACH TO THE IDENTIFICATION, APPRAISAL, AND USE OF HEALTH STATE UTILITY VALUES FOR REIMBURSEMENT DECISION MAKING. Value in Health. S63-S64. 2019
- PNS88 IMPACT OF PATIENT-TARGETED FINANCIAL INCENTIVES ON HEALTHCARE COSTS: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS. Value in Health. S300-S301. 2019
- A META-EPIDEMIOLOGICAL SURVEY OF THE REPORTING OF EFFECT MODIFICATION IN NETWORK META-ANALYSES. Value in Health. A330-A330. 2017
- The Efficacy and Safety of Biological Disease Modifying Anti-Rheumatic Drugs and Apremilast in the Treatment of Psoriatic Arthritis: A Systematic Review and Meta-Analysis. Arthritis & Rheumatology. S692-S692. 2014
journal articles
- Unmet needs in relapsed/refractory mantle cell lymphoma (r/r MCL) post-covalent Bruton tyrosine kinase inhibitor (BTKi): a systematic literature review and meta-analysis. Leukemia and Lymphoma. 65:1-14. 2024
- MM-357 Systematic Literature Review and Meta-Analysis of Clinical Trials of Fourth Line or Higher Treatment for Relapsed/Refractory Multiple Myeloma Patients. Clinical Lymphoma, Myeloma and Leukemia. 24:s551. 2024
- P-063 Systematic Literature Review and Meta-Analysis of Clinical Trials of Fourth Line or Higher Treatment for Relapsed/Refractory Multiple Myeloma Patients. Clinical Lymphoma, Myeloma and Leukemia. 24:s77-s78. 2024
- Systematic Literature Review and Meta-Analysis of Clinical Trials of Fourth Line or Higher Treatment for Relapsed/Refractory Multiple Myeloma Patients. Clinical Lymphoma, Myeloma and Leukemia. 24:s237. 2024
- Cannabis for medical use versus opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised clinical trials. BMJ Open. 14:e068182-e068182. 2024
- EE688 Case for Clear Communication and Justification of Survival Extrapolation Methodology: A Review of NICE Submissions in Oncology. Value in Health. 26:s186. 2023
- MSR15 The Impact of Response Assessment Timing on Indirect Treatment Comparisons (ITCS) – A Simulation Study. Value in Health. 26:s395-s396. 2023
- MCL-373 Unmet Need in Relapsed/Refractory (RR) Mantle Cell Lymphoma (MCL) Post-Bruton Tyrosine Kinase Inhibitor (BTKi): Systematic Literature Review and Meta-Analysis. Clinical Lymphoma, Myeloma and Leukemia. 23:s461-s462. 2023
- POSTER: MCL-373 Unmet Need in Relapsed/Refractory (RR) Mantle Cell Lymphoma (MCL) Post-Bruton Tyrosine Kinase Inhibitor (BTKi): Systematic Literature Review and Meta-Analysis. Clinical Lymphoma, Myeloma and Leukemia. 23:s212. 2023
- Theory and practice of Bayesian and frequentist frameworks for network meta-analysis. BMJ Evidence-Based Medicine. 28:204-209. 2023
- UNMET NEED IN RELAPSED/REFRACTORY (R/R) MANTLE CELL LYMPHOMA (MCL) POST‐BRUTON TYROSINE KINASE INHIBITOR (BTKI): A SYSTEMATIC LITERATURE REVIEW AND META‐ANALYSIS. Hematological Oncology. 41:755-757. 2023
- Treatment outcomes for newly diagnosed, treatment-naïve TP53-mutated acute myeloid leukemia: a systematic review and meta-analysis. Journal of Hematology and Oncology. 16:19. 2023
- Azacitidine Monotherapy in Patients With Treatment-Naïve Higher-risk Myelodysplastic Syndrome: A Systematic Literature Review and Meta-analysis. Clinical Lymphoma, Myeloma and Leukemia. 23:127-137. 2023
- Reverse Total Shoulder Arthroplasty Is the Most Cost-effective Treatment Strategy for Proximal Humerus Fractures in Older Adults: A Cost-utility Analysis. Clinical Orthopaedics and Related Research. 480:2013-2026. 2022
- Clinical outcomes associated with azacitidine (AZA) monotherapy for treatment-naïve, higher-risk myelodysplastic syndrome (HR-MDS): A systematic literature review and meta-analysis.. Journal of Clinical Oncology. 40:e19062-e19062. 2022
- Treatment outcomes for newly diagnosed, untreated TP53-mutated acute myeloid leukemia: A systematic review and meta-analysis.. Journal of Clinical Oncology. 40:e19020-e19020. 2022
- POSC427 Platform Trials: A Path to Efficient Decision Making and Faster Drug Approvals for Health Technology Assessment Bodies. Value in Health. 25:S276-S276. 2022
- Comparing the use of aggregate data and various methods of integrating individual patient data to network meta-analysis and its application to first-line ART. BMC Medical Research Methodology. 21:60. 2021
- Towards Transparency in the Selection of Published Health Utility Inputs in Cost-Utility Analyses: The Health Utility Application Tool (HAT). PharmacoEconomics (Auckland). 39:1075-1084. 2021
- Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists. European Journal of Health Economics. 22:723-733. 2021
- Clinical Trial Data Sharing for COVID-19–Related Research. Journal of Medical Internet Research. 23:e26718-e26718. 2021
- Heterogeneity in renal end points of cardiovascular outcomes trials in Type 2 diabetes. Journal of Comparative Effectiveness Research. 10:169-173. 2021
- Reporting and design of randomized controlled trials for COVID-19: A systematic review. Contemporary Clinical Trials. 101:106239-106239. 2021
- Efficacy of Treatments for Polycystic Ovarian Syndrome Management in Adolescents. Journal of the Endocrine Society. 5:bvaa155. 2021
- Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: A systematic literature review and network meta-analysis. EClinicalMedicine. 28:100573-100573. 2020
- Conservative Intervention Strategies for Adult Cancer-Related Lymphedema: A Systematic Review and Network Meta-Analysis. Oncology Nursing Forum. 47:E171-E189. 2020
- PNS18 IMPROVING THE APPLICATION OF PUBLISHED HEALTH UTILITIES IN COST-UTILITY ANALYSES: DEVELOPMENT OF THE HEALTH UTILITY APPLICATION TOOL (HAT). Value in Health. 23:S286-S287. 2020
- An Exploratory Analysis of Predictors of Concordance Between Canadian Common Drug Review Reimbursement Recommendations and the Subsequent Decisions by Ontario, British Columbia and Alberta. Healthcare Policy. 15:90-101. 2020
- Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: A systematic literature review and meta-analysis. EClinicalMedicine. 18:100237-100237. 2020
- The Landscape of Emerging Randomized Clinical Trial Evidence for COVID-19 Disease Stages: A Systematic Review of Global Trial Registries. Infection and Drug Resistance. Volume 13:4577-4587. 2020
- Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols. Trials. 20:572. 2019
- PDB3 HETEROGENEITY IN RENAL COMPOSITE ENDPOINTS IN CARDIOVASCULAR OUTCOMES TRIALS IN TYPE 2 DIABETES (T2D). Value in Health. 22:S572-S572. 2019
- PNS278 A REVIEW OF HEALTH TECHNOLOGY ASSESSMENT GUIDELINES ON THE APPROVAL OF BIOSIMILARS. Value in Health. 22:S810-S810. 2019
- Reporting of master protocols towards a standardized approach: A systematic review. Contemporary Clinical Trials Communications. 15:100406-100406. 2019
- A Profile of Older Adults With a History of Stroke Receiving Home Care in Ontario, Canada. Home Health Care Management and Practice. 31:162-171. 2019
- Health Utility Book (HUB)–Cancer: Protocol for a Systematic Literature Review of Health State Utility Values in Cancer. MDM Policy and Practice. 4:238146831985259-238146831985259. 2019
- Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacy. Clinical Research in Cardiology. 108:487-509. 2019
- Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB). Medical decision making. 39:371-379. 2019
- How do financial (dis)incentives influence health behaviour and costs? Protocol for a systematic literature review of randomised controlled trials. BMJ Open. 9:e024694-e024694. 2019
- Network meta-analysis of therapies for previously untreated advanced BRAF-mutated melanoma. Cancer Treatment Reviews. 74:43-48. 2019
- Interventions to improve birth outcomes of pregnant women living in low- and middle-income countries: a systematic review and network meta-analysis. Gates Open Research. 3:1657-1657. 2019
- Change in Prolactin Levels in Pediatric Patients Given Antipsychotics for Schizophrenia and Schizophrenia Spectrum Disorders: A Network Meta-Analysis. Schizophrenia Research and Treatment. 2018:1-9. 2018
- Deficiencies in addressing effect modification in network meta-analyses: a meta-epidemiological survey. Journal of Clinical Epidemiology. 88:47-56. 2017
- Liraglutide Versus SGLT-2 Inhibitors in People with Type 2 Diabetes: A Network Meta-Analysis. Diabetes Therapy. 8:85-99. 2017
- Prolactin-related adverse events and change in prolactin levels in pediatric patients given antipsychotics for schizophrenia and schizophrenia spectrum disorders: A systematic review. BMC Pediatrics. 16:181. 2016
- What Is the Link Between Corporal Punishment and Child Physical Abuse?. Journal of Family Violence. 30:135-148. 2015
- Highlights of the Canadian Frailty Network (CFN) Highly Qualified Personnel Poster Session. Canadian Geriatrics Journal. 22:75-98.
- Interventions to improve birth outcomes of pregnant women living in low- and middle-income countries: a systematic review and network meta-analysis. Gates Open Research. 3:1657-1657.
- P1204: AXICABTAGENE CILOLEUCEL VEIN‐TO‐VEIN TIME IN TRIAL OR REAL‐WORLD SETTINGS VS OTHER CAR T‐CELL THERAPIES FOR RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA: A SYSTEMATIC LITERATURE REVIEW AND META‐ANALYSIS. HemaSphere. 7:e7340170.
- P552: TREATMENT OUTCOMES IN NEWLY DIAGNOSED, UNTREATED PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS. HemaSphere. 6:451-452.
- P774: CLINICAL OUTCOMES ASSOCIATED WITH AZACITIDINE MONOTHERAPY FOR TREATMENT-NAIVE PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROME (HR MDS): A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS. HemaSphere. 6:669-670.
preprints